reports
Indkaldelse til ordinær generalforsamling 2025 i NewCap Holding A/S
Indkaldelse til ordinær generalforsamling 2025 i NewCap Holding A/S Selskabsmeddelelse nr. 3 / 2025 7. april 2025 Indkaldelse til ordinær generalforsamling 2025 i NewCap Holding A/S Den ordinære generalforsamling i NewCap Holding A/S afholdes tirsdag den 29. april 2025, kl. 09:30 på adressen Oslo Plads 2, 2100 København Ø. Generalforsamlingen afholdes som en fysisk generalforsamling. Aktionærerne har mulighed for at følge – men ikke deltage i - generalforsamlingen via livestreaming. Aktionærer, der ønsker at følge generalforsamlingen via livestream, opfordres til at stemme forud for gen...
Scope Metals Group Ltd: 1 director
A director at Scope Metals Group Ltd bought 8,500 shares at 119.613ILS and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
AU Small Finance Bank Limited: 1 director
A director at AU Small Finance Bank Limited bought 22,544 shares at 534.150INR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatm...
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia pain in two pivotal double-blind randomized Phase 3 studies FDA Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025, for TNX-102 SL for the management of fibr...
Plymouth Industrial REIT Provides Activity Update for First Quarter 20...
Plymouth Industrial REIT Provides Activity Update for First Quarter 2025 Announces Details for First Quarter Earnings Conference Call BOSTON, April 07, 2025 (GLOBE NEWSWIRE) -- (NYSE: PLYM) (the “Company” or “Plymouth”) provided an activity update for the first quarter of 2025. The Company also announced details for its first quarter earnings conference call and webcast to be held on May 2, 2025. Jeff Witherell, Chief Executive Officer and Co-Founder of Plymouth, noted, “Our strong leasing activity in the first quarter underscores the continued demand for well-located, functional indu...
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets...
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity -- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p
Standard Uranium Executes Letter of Intent to Option Corvo Project in ...
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2025) - Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce that it has signed a letter of intent (the "LOI"), dated April 4, 2025, with Vital Battery Metals Inc. (CSE: VBAM) (OTCQB: VBAMF) (FSE: C0O) (the "Optionee"), an arms-length party. Pursuant to the LOI, the Optionee will be granted the option (the "Option") to acquire a seventy-five percent interest in the 12,265-hectare Corvo Project ("Corvo" or the "Project") located in the eastern Athabasca Basin region (Fi...
Signify share repurchase period update
Signify share repurchase period update Press ReleaseApril 07, 2025Signify share repurchase period update Eindhoven, the Netherlands – (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 131,068 shares in the period March 31 to April 04, 2025. The shares were repurchased at an average price of EUR 19.22 per share and an aggregate amount of EUR 2.5 million. Signify will use these repurchased shares to cover obligations arising from Signify’s long-term incentive performance share plan and other employee share plans.The repurchases were made as part of the ...
Shoals Technologies Group, Inc. Announces First Quarter 2025 Earnings ...
Shoals Technologies Group, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call PORTLAND, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2025 results before market open on Tuesday, May 6, 2025, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company's website at . An archived replay of the webcast will...
Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft ...
Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer Atwater Light Brings a Crafted Touch to Low-Calorie beer, Inspired by the Spirit of Detroit DETROIT, April 07, 2025 (GLOBE NEWSWIRE) -- , Detroit’s renowned craft brewery and a craft beer brand of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of Atwater Light, a low-calorie, low-carb addition to its flagship line available year-round. This new product is now offered at local retailers and all three Atwater Tap Rooms and is anticipated to become a preferred choice for beer ent...
Castle Biosciences Honored with a Top Workplaces USA Award for Fourth ...
Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year FRIENDSWOOD, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received a Top Workplaces USA Award for the fourth consecutive year. The national award program by Energage and USA Today celebrates organizations with 150 or more employees that have built exceptional workplace cultures. Castle was ranked 30th among 358 participating U.S. companies with 500-999 employees....
ADMA Biologics Statement on Tariffs
ADMA Biologics Statement on Tariffs Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today provided a statement on the recent tariffs put in place and reiterated ADMA’s strategic advantage through fully U.S.-base...
Update on Extraordinary General Meeting – Extension of Zijin Put Optio...
Update on Extraordinary General Meeting – Extension of Zijin Put Option and Exclusivity Arrangements TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 12 March 2025 in relation to an Extraordinary General Meeting (EGM) to be held on Friday, 11 April 2025. The EGM included a resolution to approve the exercise of a put option previously granted by the Company’s major shareholder and joint venture partner, Zijin Mining Group Co. Ltd (Zijin), to allow the Company to dispose of a 25% interest in Khu...
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results ...
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline data expected in 2H2026Orphan medicinal product designation granted to deucrictibant in Europe for the treatment of bradykinin-mediated angioedemaData presented at recent congresses reinforces the value of deucri...
Notice to the Annual General Meeting
Notice to the Annual General Meeting COMPANY ANNOUNCEMENT NO 19/2025 - April 7, 2025 To the shareholders of Royal Unibrew A/SCVR No 41 95 67 12The Board of Directors of Royal Unibrew A/S hereby gives notice of the Company’s Annual General Meeting 2025 Tuesday, April 29, 2025, at 4 pm (CEST) The Annual General Meeting will be held as a fully electronic general meeting with no physical attendance in accordance with the Company’s Articles of Association Agenda and full contents of the proposals: 1. Report on the Company’s business activities during the year 2. Presen...
Brookfield Asset Management to Host First Quarter 2025 Results Confere...
Brookfield Asset Management to Host First Quarter 2025 Results Conference Call NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM), a leading global alternative asset manager headquartered in New York with over $1 trillion of assets under management, will host its first quarter 2025 conference call and webcast on Tuesday, May 6, 2025, at 11:00 a.m. ET. Results will be released that morning prior to 7:00 a.m. ET and will be available on our website at . Participants can join by conference call or webcast: Conference Call Please pre-regis...
Healthcare Realty Names Peter A. Scott President and Chief Executive O...
Healthcare Realty Names Peter A. Scott President and Chief Executive Officer NASHVILLE, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced that its Board of Directors (“Board”) has unanimously appointed Peter A. Scott to be the Company’s President and Chief Executive Officer following an extensive and rigorous search process. He will be based at the Company’s Nashville headquarters and assume his new role on April 15, 2025. Mr. Scott is expected to be added to the Board following the Company’s 2...
EQS-News: Savills: Top-6-Büromärkte
Emittent / Herausgeber: Savills Immobilien Beratungs-GmbH / Schlagwort(e): Immobilien/Research Update Savills: Top-6-Büromärkte 07.04.2025 / 12:39 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 07. April 2025 Top-6-Büromärkte: Mehr Dynamik durch Großanmietungen Flächenumsatz: Im 1. Quartal 2025 belief sich der Flächenumsatz auf 674.900 m², was einem Zuwachs von rund 13 % gegenüber dem Vorjahresquartal entsprach. In den letzten vier Quartalen lag der Flächenumsatz an den Top-6-Bürovermietungsmärkten bei 2,4 Mio. m² und damit...
Holding(s) in Company
Holding(s) in Company Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Amaroq Minerals Ltd.1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuerX2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voti...
- Research Department
ESTRATEGIA SEMANAL DE CRÉDITO: EL MERCADO PONE EN PRECIO EL PEOR ESCEN...
Entorno: Finalmente el peor escenario arancelario en EE.UU. se cumplió y trajo consigo una búsqueda de refugio donde la deuda soberana centró las compras en detrimento del crédito de menor calidad. El mercado se muestra muy preocupado por el impacto en crecimiento, con algo más de -100 p.b. de bajadas descontados ahora por los Fed Funds para 2025, y de momento, no tanto en la inflación. Esta semana en EE.UU. tendremos las actas de la última reunión de la Fed, inflación de marzo (sin impactos tod...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.